TY - JOUR
T1 - Association Between Plasma Antibody Responses and Risk for Cryptococcus-Associated Immune Reconstitution Inflammatory Syndrome
AU - Yoon, Hyun Ah
AU - Nakouzi, Antonio
AU - Chang, Christina C.
AU - Kuniholm, Mark H.
AU - Carreño, Leandro J.
AU - Wang, Tao
AU - Ndung'u, Thumbi
AU - Lewin, Sharon R.
AU - French, Martyn A.
AU - Pirofski, Liise Anne
N1 - Funding Information:
Financial support. This work was supported by the National Institutes of Health (grant number R01 AI 097096 to L. P.); Australian National Health and Medical Research Council Early Career Fellowship (grant number APP1092160 to C. C. C) and Practitioner Fellowship to S. R. L.; Howard Hughes Medical Institute International Early Career Scientist Award to T. N.; Wellcome Trust through the Sub-Saharan African Network for TB/HIV Research Excellence (grant number DEL-15-006 to T. N.); and the South African National Research Foundation Research Chairs Initiative to T. N.
Funding Information:
Potential conflicts of interest. S. R. L. has received grants from National Health and Medical Research Council of Australia, American Foundation for AIDS Research, Danish Medical Council, University of Malaya, Gilead Sciences, Merck, ViiV, and Tetralogic/Shape Pharmaceuticals. T. N. has received grants from National Research Foundation of South Africa, Victor Daitz Foundation, and Wellcome Trust during the conduct of the study. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Publisher Copyright:
© 2018 The Author(s).
PY - 2019/1/9
Y1 - 2019/1/9
N2 - Background. Initiation of antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected individuals with cryptococcal meningitis places them at risk for Cryptococcus-associated immune reconstitution inflammatory syndrome (C-IRIS). The relationship between antibody immunity and C-IRIS risk has not been investigated. Methods. We compared plasma levels of immunoglobulins, C. neoformans glucuronoxylomannan (GXM) capsule-specific and laminarin (Lam)-binding IgM and IgG, and percentages of peripheral blood total and memory B cells between 27 HIV-infected patients with CM who developed C-IRIS and 63 who did not, and evaluated associations of these parameters with risk of C-IRIS. Results. Prior to initiation of ART, plasma IgM, Lam-binding IgM (Lam-IgM), Lam-IgG, and GXM-IgM levels were significantly lower in patients who developed C-IRIS than those who did not. Multivariate analysis revealed significant inverse associations between C-IRIS and IgM (P = .0003), Lam-IgM (P = .0005), Lam-IgG (P = .002), and GXM-IgM (P = .002) independent of age, sex, HIV viral load, CD4+ T-cell count, and cerebrospinal fluid fungal burden. There were no associations between C-IRIS and total or memory B cells. Discussion. Antibody profiles that include plasma IgM, Lam-IgM, Lam-IgG, and/or GXM-IgM may have value in furthering our understanding of C-IRIS pathogenesis and hold promise as candidate biomarkers of C-IRIS risk.
AB - Background. Initiation of antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected individuals with cryptococcal meningitis places them at risk for Cryptococcus-associated immune reconstitution inflammatory syndrome (C-IRIS). The relationship between antibody immunity and C-IRIS risk has not been investigated. Methods. We compared plasma levels of immunoglobulins, C. neoformans glucuronoxylomannan (GXM) capsule-specific and laminarin (Lam)-binding IgM and IgG, and percentages of peripheral blood total and memory B cells between 27 HIV-infected patients with CM who developed C-IRIS and 63 who did not, and evaluated associations of these parameters with risk of C-IRIS. Results. Prior to initiation of ART, plasma IgM, Lam-binding IgM (Lam-IgM), Lam-IgG, and GXM-IgM levels were significantly lower in patients who developed C-IRIS than those who did not. Multivariate analysis revealed significant inverse associations between C-IRIS and IgM (P = .0003), Lam-IgM (P = .0005), Lam-IgG (P = .002), and GXM-IgM (P = .002) independent of age, sex, HIV viral load, CD4+ T-cell count, and cerebrospinal fluid fungal burden. There were no associations between C-IRIS and total or memory B cells. Discussion. Antibody profiles that include plasma IgM, Lam-IgM, Lam-IgG, and/or GXM-IgM may have value in furthering our understanding of C-IRIS pathogenesis and hold promise as candidate biomarkers of C-IRIS risk.
KW - Cryptococcus-associated immune reconstitution inflammatory syndrome
KW - GXM
KW - HIV
KW - IgG
KW - IgM
KW - cryptococcal meningitis
KW - laminarin
KW - memory B cells
UR - http://www.scopus.com/inward/record.url?scp=85059797704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059797704&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiy447
DO - 10.1093/infdis/jiy447
M3 - Article
C2 - 30010905
AN - SCOPUS:85059797704
SN - 0022-1899
VL - 219
SP - 420
EP - 428
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 3
ER -